Sanofi's Lantus shows no cancer, heart risks: study
10:22 EDT 11 Jun 2012 | Reuters
PARIS (Reuters) - Sanofi's insulin Lantus does not put people at risk of cancer, heart attacks or strokes when taken over long periods, according to a major study in which the drug failed to prove it can prevent heart disease in early-stage diabetics..
Original Article: Sanofi's Lantus shows no cancer, heart risks: study
More From BioPortfolio on "Sanofi's Lantus shows no cancer, heart risks: study"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
